Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 5 versus OSMITROL 5 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 5 versus OSMITROL 5 IN WATER.
MANNITOL 5% vs OSMITROL 5% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into the extracellular fluid and vasculature, thereby reducing intracranial and intraocular pressure. It also increases renal tubular osmotic pressure, inhibiting water reabsorption and promoting diuresis.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular and interstitial spaces into the extracellular compartment, thereby reducing cerebral edema and intraocular pressure; also promotes diuresis by increasing renal tubular fluid osmolality.
Intravenous infusion of 50-100 g (as a 5% solution) over 2-6 hours, typically 500-1000 mL, for osmotic diuresis; or for reduction of intracranial pressure, 1-2 g/kg IV over 30-60 minutes as a 15-25% solution.
50-100 g intravenously as a 5% solution over 30-60 minutes; may repeat every 6-8 hours as needed. Maximum dose: 200 g in 24 hours.
None Documented
None Documented
Terminal: 0.25–1.5 h (prolonged in renal impairment); clinical context: accumulates in renal failure, monitor serum osmolarity and renal function
Approximately 0.25-1.5 hours (15-90 minutes); prolonged in renal impairment or with mannitol accumulation (e.g., in anuria).
Renal: 90% unchanged; biliary/fecal: negligible (<2%)
Primarily renal (90-100% unchanged in urine); negligible biliary or fecal elimination.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic